Results: Kathmandu share price set to push higher

The Kathmandu Holdings Ltd (ASX:KMD) share price will be on watch on Tuesday following the release of the retailer's half year results…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Kathmandu Holdings Ltd (ASX: KMD) share price will be on watch on Tuesday following the release of the outdoor retailer's record half year results.

At the time of writing the company's New Zealand-listed shares are up 3%.

Here's a summary of how Kathmandu performed in the first half compared to the prior corresponding period:

  • Sales increased 13.3% to NZ$232 million.
  • Same store sales flat in constant currency and down 2% at current exchange rates.
  • Gross profit rose 9.4% to NZ$141.9 million.
  • Normalised net profit after tax up 7.3% to NZ$13.2 million.
  • Summit Club grows to 2 million members.
  • Interim dividend of 4 New Zealand cents per share.

What happened?

Although Kathmandu delivered a record half year result, it was a disappointing six months given the impressive start the company had. This was the result of softer trading conditions in Australia and New Zealand over the key Christmas and Boxing Day period.

However, management did warn the market about this with the release of a trading update in January, so this result was largely in line with reduced expectations.

One positive during the half was that despite sales being below expectations, the company experienced an improvement in its retail gross margin. Kathmandu's retail gross margin increased 0.8% points from 63.4% to 64.2% due to less promotional discounting, leading to higher average selling prices.

Another positive was the performance of the recently acquired Oboz business. During the half the business continued its strong growth, with sales increasing 38.6% to NZ$29.2 million.

This strong form meant the Oboz business achieved its earn-out EBITDA target. As a result, Oboz is expected to be neutral to group earnings per share in FY 2019, but earnings per share accretive in FY 2020.

Outlook.

The company's CEO, Xavier Simonet, appeared cautious on its prospects in the second half.

He said: "We remain focused on achieving sales and profit growth in our core Australasian business to fund investment for future growth. Our full year result is still very dependent on the key promotions to come, in which we will be cycling a successful second half last year."

Should you invest?

Whilst I think that Kathmandu's shares are trading at an attractive level, I was a touch underwhelmed by this result and its outlook for the remainder of the year.

In light of this, I would suggest investors focus on other retail shares such as Accent Group Ltd (ASX: AX1) and Super Retail Group Ltd (ASX: SUL) instead.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Super Retail Group Limited. The Motley Fool Australia has recommended Accent Group. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »